You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thiotepa

Showing 26 - 50 of 307
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis Trial in Italy (A: Fludarabine + Busulphan, B: Fludarabine + Thiotepa)

Completed
  • Myelofibrosis
  • A: Fludarabine + Busulphan
  • B: Fludarabine + Thiotepa
  • Alessandria, Italy
  • +20 more
Aug 19, 2021

Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA

Recruiting
  • Sickle Cell Anemia
  • +2 more
  • CD3/CD19 depleted leukocytes
  • +6 more
  • Pittsburgh, Pennsylvania
    Children's Hospital of Pittsburgh of UPMC
May 4, 2022

Malignant Lymphoma Trial in Ramat Gan (Thiotepa)

Recruiting
  • Malignant Lymphoma
  • Thiotepa
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
Oct 21, 2020

Neuroblastoma Trial in Guangzhou (Anti Thymocyte Globulin, Fludarabine, Cyclophosphamide injection)

Not yet recruiting
  • Neuroblastoma
  • Anti Thymocyte Globulin
  • +10 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 29, 2022

Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)

Active, not recruiting
  • Hematologic Malignancy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Brain Tumors Trial in Canada, United States (temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid)

Completed
Has Results
  • Brain Tumors
  • temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid
  • Phoenix, Arizona
  • +16 more
Jun 17, 2021

Idiopathic Pulmonary Fibrosis, Emphysema or COPD Trial in Pittsburgh (CD3/CD19 negative hematopoietic stem cells, Rituximab,

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Emphysema or COPD
  • CD3/CD19 negative hematopoietic stem cells
  • +6 more
  • Pittsburgh, Pennsylvania
  • +1 more
Feb 9, 2022

Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant

Recruiting
  • Immune Deficiency Disorders
  • +13 more
  • Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
  • Saint Louis, Missouri
    Washington University
Apr 25, 2022

Hematological Disease, Immune Deficiencies, Solid Tumors Trial in Rochester (radiation, drug, procedure)

Completed
  • Hematological Disease
  • +5 more
  • Total Body Irradiation 1200 cGy
  • +9 more
  • Rochester, New York
    Wilmot Cancer Institute
Nov 1, 2021

Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)

Recruiting
  • Crohn's Disease
  • autologous CD34-selected peripheral blood stem cells transplant
  • +8 more
  • Pittsburgh, Pennsylvania
  • +1 more
Feb 9, 2022

Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,

Active, not recruiting
  • Acute Lymphoid Leukemia (ALL)
  • +5 more
  • Hyperfractionated total body irradiation
  • +9 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease Trial in Pittsburgh (Cyclophosphamide, Mesna,

Recruiting
  • Systemic Sclerosis
  • +3 more
  • Pittsburgh, Pennsylvania
  • +2 more
Dec 17, 2021

Acute Myeloid Leukaemia, Myelodysplasia Trial in Birmingham (Vyxeos, Fludarabine, Busulphan)

Recruiting
  • Acute Myeloid Leukaemia
  • Myelodysplasia
  • Birmingham, United Kingdom
    Queen Elizabeth Hospital
Oct 14, 2021

Severe Combined Immunodeficiency Trial in Memphis (drug, device, other)

Recruiting
  • Severe Combined Immunodeficiency
  • Anti-thymocyte globulin (rabbit)
  • +5 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 6, 2021

CNS Cancer, CNS BRAIN Trial in Basking Ridge, Commack, New York (temozolomide followed by high dose busulfan and thiotepa)

Active, not recruiting
  • CNS Cancer
  • CNS BRAIN
  • temozolomide followed by high dose busulfan and thiotepa
  • Basking Ridge, New Jersey
  • +2 more
Oct 7, 2021

Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,

Not yet recruiting
  • Acute Leukemia of Ambiguous Lineage
  • +8 more
  • Biospecimen Collection
  • +12 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 22, 2023

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Seattle

Recruiting
  • Acute Biphenotypic Leukemia
  • +5 more
  • Dilanubicel
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 11, 2022

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Buffalo (biological, drug, radiation)

Completed
Has Results
  • Chronic Myeloproliferative Disorders
  • +7 more
  • anti-thymocyte globulin
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 19, 2021

Chronic Myeloid Leukemia Trial in Austria, Czechia, Italy (Fludarabine, Thiotepa, Melphalan)

Completed
  • Chronic Myeloid Leukemia
  • Graz, Austria
  • +3 more
Apr 14, 2021

Very High Risk Neuroblastoma Trial in Villejuif, Utrecht (radiation, drug, procedure)

Recruiting
  • Very High Risk Neuroblastoma
  • 131I-mIBG
  • +3 more
  • Villejuif, Val De Marne, France
  • +1 more
May 31, 2021

Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

Recruiting
  • Acute Erythroid Leukemia
  • +10 more
  • San Francisco, California
  • +5 more
Nov 1, 2022

Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)

Recruiting
  • Anaplastic Ependymoma
  • +14 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 17, 2022

Neuroblastoma Trial in Lund (iodine I 131 metaiodobenzylguanidine, Fludarabine, Thiotepa)

Active, not recruiting
  • Neuroblastoma
  • iodine I 131 metaiodobenzylguanidine
  • +7 more
  • Lund, Sweden
    Lund University Hospital, Department of Pediatric Oncology and B
Feb 17, 2021

Breast Cancer Trial in Netherlands (Carboplatin and Paclitaxel, Doxorubicin, cyclophosphamide, Doxorubicin, cyclophosphamide,

Active, not recruiting
  • Breast Cancer
  • Carboplatin and Paclitaxel
  • +2 more
  • Alkmaar, Netherlands
  • +13 more
Oct 18, 2021

High-risk Medulloblastoma Trial in Villejuif (Carboplatin + etoposide, Thiotepa, Cyclophosphamide + Busilvex)

Active, not recruiting
  • High-risk Medulloblastoma
  • Carboplatin + etoposide
  • +2 more
  • Villejuif, Val De Marne, France
    Gustave Roussy
Feb 23, 2021